Signal active
Organization
Contact Information
Overview
VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary next generation i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
About
Biotechnology, Health Care, Medical, Medical Device
2012
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VLP Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $2.8B in funding across 64 round(s). With a team of 1-10 employees, VLP Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - VLP Therapeutics, raised $2.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
0
0
$43.3M
Details
2
VLP Therapeutics has raised a total of $43.3M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Early Stage Venture | 16.0M | ||
2021 | Early Stage Venture | 21.0M |
Investors
VLP Therapeutics is funded by 15 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Miyako Capital | - | FUNDING ROUND - Miyako Capital | 21.0M |
SK Impact Fund | - | FUNDING ROUND - SK Impact Fund | 21.0M |
MUFG Bank | - | FUNDING ROUND - MUFG Bank | 21.0M |
VLP Therapeutics | - | FUNDING ROUND - VLP Therapeutics | 21.0M |
Recent Activity
There is no recent news or activity for this profile.